Advertisement
COSTA MESA, Calif., Dec. 26, 2018 /PRNewswire-PRWeb/ -- StudyKIK, a patient recruitment company headquartered in Costa Mesa, California announced to their attendance at the 2019 JP Morgan Healthcare Conference. The patient recruitment company has been involved in referring over 400,000 patients in 2018 alone into clinical trials globally. At the JP Morgan Healthcare Conference, StudyKIK will be holding multiple meetings to discuss how the clinical trial recruitment environment is changing due to protocol complexity and the need for technologies to further fulfill the enrollment goals of such clinical trials.
StudyKIK is a patient recruitment company that builds digital patient communities across multiple social media platforms to build awareness of clinical trials, spark patient engagement, and refer qualified patients to enrolling research sites. The company is currently utilized by over 7,000 research site users for patient sourcing and operational management. From the company's inception, StudyKIK has been focusing on 2 main initiatives, to build the most engaged patient communities in the industry for clinical trial awareness and provide all needed communication tools for research sites to streamline the site burden recruitment initiatives that has been known to incur on sites. Due to the accomplishment of this, StudyKIK is the fastest growing patient recruitment company to service Pharmaceutical Companies, Contract Research Organizations, and Research sites in the industry.
The CEO/ Co-Founder Matt Miller and Chief Innovation Officer/ Co-Founder Jerome Chiaro will be in attendance at the JP Morgan Conference. To set a time to meet with them, please email [email protected] to schedule a time to meet.
More about StudyKIK:
StudyKIK is a patient recruitment platform that builds communities on all major social media channels to increase awareness for clinical trials. Servicing over 7,000 research site users, StudyKIK owns hundreds of social media patient and caregiver communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest to connect patients to clinical trials. They have addressed the clinical trial patient recruitment problem by building the tools needed for research sites and pharmaceutical companies to access, manage, and communicate with high quality patients in real-time.
SOURCE StudyKIK
Advertisement
StudyKIK is a patient recruitment company that builds digital patient communities across multiple social media platforms to build awareness of clinical trials, spark patient engagement, and refer qualified patients to enrolling research sites. The company is currently utilized by over 7,000 research site users for patient sourcing and operational management. From the company's inception, StudyKIK has been focusing on 2 main initiatives, to build the most engaged patient communities in the industry for clinical trial awareness and provide all needed communication tools for research sites to streamline the site burden recruitment initiatives that has been known to incur on sites. Due to the accomplishment of this, StudyKIK is the fastest growing patient recruitment company to service Pharmaceutical Companies, Contract Research Organizations, and Research sites in the industry.
The CEO/ Co-Founder Matt Miller and Chief Innovation Officer/ Co-Founder Jerome Chiaro will be in attendance at the JP Morgan Conference. To set a time to meet with them, please email [email protected] to schedule a time to meet.
More about StudyKIK:
StudyKIK is a patient recruitment platform that builds communities on all major social media channels to increase awareness for clinical trials. Servicing over 7,000 research site users, StudyKIK owns hundreds of social media patient and caregiver communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest to connect patients to clinical trials. They have addressed the clinical trial patient recruitment problem by building the tools needed for research sites and pharmaceutical companies to access, manage, and communicate with high quality patients in real-time.
SOURCE StudyKIK
